Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 26.56 USD -6.77% Market Closed
Market Cap: 5.8B USD
Have any thoughts about
Hims & Hers Health Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one HIMS stock under the Base Case scenario is 19.94 USD. Compared to the current market price of 26.56 USD, Hims & Hers Health Inc is Overvalued by 25%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HIMS Relative Value
Base Case
19.94 USD
Overvaluation 25%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.7
P/S
P/S
Price to Sales
4.7
vs History
20
vs Industry
28
Median 3Y
3.2
Median 5Y
2.8
Industry
2.3
Forward
4
More Details
57.1
P/E
P/E
Price to Earnings
57.1
vs History
9
vs Industry
Median 3Y
-16
Median 5Y
-32.7
Industry
23.2
Forward
48.5
More Details
31
P/OCF
P/OCF
Price to OCF
31
vs History
23
vs Industry
6
Median 3Y
25.2
Median 5Y
-39.8
Industry
14.3
More Details
38.7
P/FCFE
P/FCFE
Price to FCFE
38.7
vs History
23
vs Industry
7
Median 3Y
-19.1
Median 5Y
-39.9
Industry
20.1
More Details
13.1
P/B
P/B
Price to Book Value
13.1
vs History
3
vs Industry
4
Median 3Y
5.5
Median 5Y
4.2
Industry
2.2
More Details
4.6
EV/S
EV/S
Enterprise Value to Sales
4.6
vs History
20
vs Industry
27
Median 3Y
2.8
Median 5Y
2.5
Industry
2.4
Forward
3.8
More Details
5.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.6
vs History
20
vs Industry
41
Median 3Y
3.6
Median 5Y
3.1
Industry
5
More Details
96.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
96.7
vs History
9
vs Industry
100
Median 3Y
-13.8
Median 5Y
-32.3
Industry
12.8
Forward
31.8
More Details
126.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
126.2
vs History
4
vs Industry
Median 3Y
-14.7
Median 5Y
-31.7
Industry
17.2
Forward
79.5
More Details
30.4
EV/OCF
EV/OCF
Enterprise Value to OCF
30.4
vs History
20
vs Industry
7
Median 3Y
22.9
Median 5Y
-31.8
Industry
14
More Details
37.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37.9
vs History
23
vs Industry
5
Median 3Y
-14.5
Median 5Y
-34.2
Industry
18.2
More Details
20.8
EV/IC
EV/IC
Enterprise Value to IC
20.8
vs History
14
vs Industry
4
Median 3Y
9.5
Median 5Y
7.4
Industry
1.9
More Details

Multiples Across Competitors

HIMS Competitors Multiples
Hims & Hers Health Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Hims & Hers Health Inc
NYSE:HIMS
5.9B USD 4.7 57.1 96.7 126.2
US
Cigna Group
XMUN:CGN
75.6B EUR 0.3 25.9 8.1 10.4
US
Cigna Corp
NYSE:CI
77.9B USD 0.3 25.6 8 10.3
US
CVS Health Corp
NYSE:CVS
56B USD 0.2 11.2 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
26B EUR 1.3 49 11.2 25.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.8B EUR 0.9 -49.2 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.3B USD 1.5 44.3 13.2 20.4
US
R1 RCM Inc
NASDAQ:RCM
16.9B USD 6.9 -275.9 36.7 94.9
US
Quest Diagnostics Inc
NYSE:DGX
17.1B USD 1.8 20.4 12.3 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 24.5 7.1 16.4
US
DaVita Inc
NYSE:DVA
12.7B USD 1 15.4 8 11.1

See Also

Summary
HIMS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HIMS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HIMS stock valuation using valuation multiples.
Wall Street Estimates
HIMS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HIMS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.